Shining Light on Clinicians Serving the Hereditary Blood Disorders Community Introducing Dr. Prantar Chakrabarti MD, DBN, DM, a renowned Clinical hematologist with a specialty in Thalassemia, Hemoglobinopathies, and Bleeding disorders like hemophilia A, hemophilia B, and Von Willebrand disease. GANSID: What hereditary blood disorder/s do you treat and what leads you to that specialty area? Dr. Prantar: The hereditary blood disorders that I usually treat are thalassemia, hemoglobinopathies, and bleeding disorders like hemophilia A, hemophilia
Dr. Titi Adeyemo Shining Light on Clinicians Serving the Hereditary Blood Disorders Community Introducing Dr. Titi Adeyemo, a hematologist with a specialty in Sickle Cell Disease, Thalassemia, and Hemophilia Clinicians around the world play a vital role in supporting individuals living with hereditary blood disorders (HBDs). Their dedication, expertise, and compassion significantly impact the lives of patients and their families. In this blog post, we are honored to share Dr. Titi Adeyemo’s story. She is
As we observe Black History Month in the USA, Canada, UK and the Ireland, I take pride in acknowledging the remarkable contributions made by Black pioneers in the fight against inherited blood disorders. This month provides us with the opportunity to reflect on the significant impact Black individuals and communities have had in shaping our world, especially in advancing inherited blood disorders including sickle cell disease. The Global Action Network for Sickle Cell & Other
CASGEVY: A Cure for Sickle Cell & Thalassemia Disorders. Thornton, Canada, November 17, 2023, Casgevy by the Boston-based pharmaceutical company, Vertex is the first medicine to be licensed that uses the innovative genome-editing tool CRISPR, for which its inventors (Emmanuelle Charpentier of the Max Planck Unit for the Science of Pathogens and Jennifer Doudna of the University of California, Berkeley) were awarded the Nobel Prize in Chemistry in 2020 The inventors first showed that CRISPR—which